Biolabs, Inc.
United StatesFDA applicant, unverified
- Devices
- 3
What Biolabs, Inc. makes
Biolabs, Inc. manufactures bovine-derived sera, including fetal bovine serum, newborn bovine serum, and bovine calf serum, used primarily as culture supplements in cell and tissue culture applications.
These products are classified as Class I medical devices under FDA regulations and are listed via the 510(k) pathway. The company is based in the United States.
Catalogue
Fetal Bovine Serum Ref K800781
Regimes: 510(k) Registry: 510(k)Newborn Bovine Serum Ref K810903
Regimes: 510(k) Registry: 510(k)Bovine Calf Serum Ref K810904
Regimes: 510(k) Registry: 510(k)
Frequently asked questions
How many devices does Biolabs, Inc. have in the registry?
The registry currently lists 3 devices for Biolabs, Inc.. Devices recorded under merged duplicate company entries are counted once.
Which registries list Biolabs, Inc.'s devices?
Among its 3 most recently registered devices, Biolabs, Inc. has devices listed in FDA 510(k) (3 devices).
What risk classes do Biolabs, Inc.'s devices fall under?
Among its 3 most recently registered devices, the classes recorded for Biolabs, Inc.'s devices are Class I. Each device page shows its own class and authorisation.
What are the newest devices from Biolabs, Inc. in the registry?
The most recently registered devices listed for Biolabs, Inc. include FETAL BOVINE SERUM, NEWBORN BOVINE SERUM and BOVINE CALF SERUM.